Literature DB >> 3007678

Severe sensorimotor neuropathy after cisplatin therapy.

M Pagès, A M Pagès, L Bories-Azeau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007678      PMCID: PMC1028740          DOI: 10.1136/jnnp.49.3.333

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  9 in total

1.  Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum(II) treatment: a case report.

Authors:  A Kedar; M E Cohen; A I Freeman
Journal:  Cancer Treat Rep       Date:  1978-05

Review 2.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

3.  Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.

Authors:  I J Piel; D Meyer; C P Perlia; V I Wolfe
Journal:  Cancer Chemother Rep       Date:  1974 Nov-Dec

4.  Peripheral neuropathy after cis-platinum (II) (DDP) therapy.

Authors:  L Reinstein; S S Ostrow; P H Wiernik
Journal:  Arch Phys Med Rehabil       Date:  1980-06       Impact factor: 3.966

5.  Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.

Authors:  D Hadley; H W Herr
Journal:  Cancer       Date:  1979-12       Impact factor: 6.860

Review 6.  Cis-diamminedichloroplatinum (II). A new anticancer drug.

Authors:  M Rozencweig; D D von Hoff; M Slavik; F M Muggia
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

7.  Neurotoxic effects of cisplatin therapy.

Authors:  T J Walsh; A W Clark; I M Parhad; W R Green
Journal:  Arch Neurol       Date:  1982-11

8.  Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II.

Authors:  R Becher; P Schütt; R Osieka; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Peripheral sensory neuropathy and cisplatin chemotherapy.

Authors:  R I Roelofs; W Hrushesky; J Rogin; L Rosenberg
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

  9 in total
  3 in total

1.  Sensorimotor neuropathy and cisplatin and adriamycin toxicity.

Authors:  J B Cavanagh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

2.  Cisplatin neuropathy: clinical course and neurophysiological findings.

Authors:  M LoMonaco; M Milone; A P Batocchi; L Padua; D Restuccia; P Tonali
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

3.  Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas.

Authors:  H M Earl; S Connolly; C Latoufis; K Eagle; C M Ash; C Fowler; R L Souhami
Journal:  Sarcoma       Date:  1998
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.